NCT07039279Recruiting
Hong Kong Diabesity Register & 3-Year Trial on Integrated Care for Chinese With Diabesity
Establishment of Hong Kong Diabesity Register and a 3-year Randomized Clinical Trial for the Investigation of the Effectiveness of a Multicomponent Integrated Care Program in Chinese With Diabesity
Source: ClinicalTrials.gov · Last updated 3 Mar 2026
Brief summary (registry, in English)
People with diabetes and obesity (diabesity) are difficult to treat with many unmet needs requiring personalized treatment regimens, intensive counselling and emotional support. Here, we propose to conduct a pragmatic trial including 2 parts: (1) establishment of a register for Hong Kong Chinese with diabesity and through this register, identify participants consecutively to enter (2) a 3-year randomized clinical trial to assess the effects of multicomponent integrated care program supported by a team of endocrinologist, dietitian, psychologist and research assistant with elements including medical therapy, cognitive behavioural therapy, e-care, artificial intelligence chatbot, biofeedback, peer support to improve the physical and mental health in people with diabesity, with weight reduction as primary outcome. Other outcomes include cardiometabolic risk factors, diabetes distress, lifestyles and sleep hygiene.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- First submitted
- 4 Jun 2025
- Start date
- 22 Oct 2025
- Primary completion date
- 31 Oct 2030
- Lead sponsor
- Chinese University of Hong Kong
- NCT number
- NCT07039279
What you commit to
- Study type: Interventional
- Planned participants: 200
- From 22 Oct 2025 to the primary completion date, 31 Oct 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Type 1 diabetes;
- Active malignant disease including those with history of malignant disease less than 5 years of disease-free duration;
- Any medical illness or condition as judged by the investigators as ineligible to participate the study.
Other
- Life expectancy less than 12 months;
Who the study is looking for
- Type 2 diabetes;
- Obesity reaching action level as defined as body mass index (BMI) ³27.5 kg/m2 and/or waist circumference (WC) ³80cm in women and ³90cm in men;
- Age between 18 and 50 years;
- Able to conversate with smartphone technology and web-based program.
- Able to read Chinese and communicate using Chinese.
Age in the registry: 18 years to 50 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Medicine and Therapeutics, The Chinese University of Hong Kong (CUHK), Ward 3M, Diabetes and Endocrine Research Centre, 3/F Day Treatment Block and Children Wards (Old Block), Prince of Wales Hospital Coordinator of this site? Confirm its status | Hong Kong | Hong Kong SAR China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.